Research & Development

亿龍彩票网址亿龍彩票下载彩票app大全下载美国三大股指集体收涨 纳指创收盘新高


  然後,劉莽第三次罰球空心命中……   所以,劉莽那不妙的預感來了。亿龍彩票网址   裁判哨響!亿龍彩票下载   劉莽和一臉不忍看下去的隊友擊掌後,再次走上罰球線。   突然,劉莽腦子里冒出一個聲音。彩票app大全下载

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo